In the rapidly evolving landscape of the life sciences, the humble lipid has moved from the periphery of research to the center of the "omics" revolution. No longer viewed simply as passive energy storage units, fatty acids are now recognized as sophisticated signaling molecules, ...Learn More

CD BioGlyco launched its Therapeutic Nucleic Acid Development Platform. The company says the platform combines nucleic acid synthesis and delivery into a single service. Most platforms only handle one or the other, according to CD BioGlyco. "We built this to save researchers ...Learn More

Glycoproteins govern everything from cell-cell communication to pathogen recognition, yet most researchers unknowingly work with a messy reality. When isolated from natural sources, these complex molecules exist as heterogeneous mixtures of related glycoforms—identical protein ...Learn More

The glycosylation pattern of proteins changes during tumor development—a fact that has positioned glycoproteins as promising early cancer biomarkers. But analyzing these complex, heterogeneous structures requires far more than standard mass spectrometry. A Glycoproteomics ...Learn More

CD BioGlyco has rolled out a newly designed nucleic acid drug delivery system for siRNA- and mRNA-based therapeutics.Built around refined glycosylation chemistry, the platform focuses on improving how molecules like siRNA and mRNA are brought into target cells. Rather than ...Learn More